In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $4.70, marking a -3.29% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.01%.

In addition to being early to the defense tech and AI trends, Lux has realized significant exits from its investment in AI ...

We recently published 10 Stocks With Massive Gains; 5 at Record Highs. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) was one ...

According to TipRanks.com, Stranahan is a 4-star analyst with an average return of 4.1% and a 52.3% success rate. Stranahan covers the Healthcare sector, focusing on stocks such as Day One ...

Peter Krull, director of Earth Equity Advisors, discusses why he's bullish on renewable energy and shares his top clean ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...

Abstract: Nowadays, Heart disease is one of the crucial impacts of mortality in the country. In clinical data analysis, predicting cardiovascular disease is a primary challenge. Deep learning (DL) has ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, ...

Eli Lilly is a well-established pharmaceutical company with a portfolio of products that consistently generate revenue and ...

Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts.

Abstract: Renewable energy sources and electric vehicles provide an effective way to reduce the energy cost of an enterprise microgrid. However, the uncertainties of renewable energy sources and the ...